Viracta Therapeutics

Viracta Therapeutics is a company listed under the stock ticker VIRX (US).

View the org chart displaying its 19 main executives

Dan Chevallard, Chief Operating Officer and Chief Financial Officer, has left the company (posted on March 22 2024).
Darrel Cohen has joined the company as Chief Medical Officer (posted on August 8 2023).

Create your alert
to follow the executive moves at Viracta Therapeutics.

Metsera has just announced a $290 Million fundraising (posted on April 23 2024).
Histogen has filed for bankruptcy protection (posted on April 19 2024).
Bruker has announced the acquisition of NanoString Technologies (posted on April 18 2024).

Contact by email its executives including Mark Rothera Premium

The best decision-maker directory

Discover the organization charts of your favorite companies.

Spot the influential executives using our search tools.

Receive notifications when executive positions change.

Fuel your company's success with our real-time data.

Individual Access

Executive Data Sets

Executives

Companies

The Official Board